Suzanne Goodrich1, Abraham Siika2, Ann Mwangi3, Monicah Nyambura4, Violet Naanyu3, Constantin Yiannoutsos5, Thomas Spira6, Moses Bateganya6, Cathy Toroitich-Ruto7, Boaz Otieno-Nyunya7, Kara Wools-Kaloustian1. 1. Division of Infectious Diseases, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN. 2. Departments of Medicine; and. 3. Behavioural Sciences, School of Medicine, College of Health Sciences, Moi University, Eldoret, Kenya. 4. Academic Model Providing Access to Healthcare (AMPATH), Eldoret, Kenya. 5. Department of Biostatistics, Indiana University Fairbanks School of Public Health, Indianapolis, IN. 6. Division of Global HIV and TB, Center for Global Health (DGHT), Centers for Disease Control and Prevention (CDC), Atlanta, GA; and. 7. DGHT, Centers for Disease Control and Prevention (CDC), Nairobi, Kenya.
Abstract
OBJECTIVE: To develop and assess an alternative care model using community-based groups for people living with HIV and facilitate by lay personnel. METHODS: Geographic locations in the Academic Model Providing Access to Healthcare Kitale clinic catchment were randomized to standard of care versus a community-based care group (ART Co-op). Adults stable on antiretroviral therapy and virally suppressed were eligible. Research Assistant-led ART Co-ops met in the community every 3 months. Participants were seen in the HIV clinic only if referred. CD4 count and viral load were measured in clinic at enrollment and after 12 months. Retention, viral suppression, and clinic utilization were compared between groups using χ2, Fisher exact, and Wilcoxon rank sum tests. RESULTS: At 12 months, there were no significant differences in mean CD4 count or viral load suppression. There was a significant difference in patient retention in assigned study group between the intervention and control group (81.6% vs 98.6%; P < 0.001), with a number of intervention patients withdrawing because of stigma, relocation, pregnancy, and work conflicts. All participants, however, were retained in an HIV care program for the study duration. The median number of clinic visits was lower for the intervention group than that for the control group (0 vs 3; P < 0.001). CONCLUSIONS: Individuals retained in a community-based HIV care model had clinical outcomes equivalent to those receiving clinic-based care. This innovative model of HIV care addresses the problems of insufficient health care personnel and patient retention barriers, including time, distance, and cost to attend clinic, and has the potential for wider implementation.
OBJECTIVE: To develop and assess an alternative care model using community-based groups for people living with HIV and facilitate by lay personnel. METHODS: Geographic locations in the Academic Model Providing Access to Healthcare Kitale clinic catchment were randomized to standard of care versus a community-based care group (ART Co-op). Adults stable on antiretroviral therapy and virally suppressed were eligible. Research Assistant-led ART Co-ops met in the community every 3 months. Participants were seen in the HIV clinic only if referred. CD4 count and viral load were measured in clinic at enrollment and after 12 months. Retention, viral suppression, and clinic utilization were compared between groups using χ2, Fisher exact, and Wilcoxon rank sum tests. RESULTS: At 12 months, there were no significant differences in mean CD4 count or viral load suppression. There was a significant difference in patient retention in assigned study group between the intervention and control group (81.6% vs 98.6%; P < 0.001), with a number of intervention patients withdrawing because of stigma, relocation, pregnancy, and work conflicts. All participants, however, were retained in an HIV care program for the study duration. The median number of clinic visits was lower for the intervention group than that for the control group (0 vs 3; P < 0.001). CONCLUSIONS: Individuals retained in a community-based HIV care model had clinical outcomes equivalent to those receiving clinic-based care. This innovative model of HIV care addresses the problems of insufficient health care personnel and patient retention barriers, including time, distance, and cost to attend clinic, and has the potential for wider implementation.
Authors: Joseph Kwong-Leung Yu; Solomon Chih-Cheng Chen; Kuo-Yang Wang; Chao-Sung Chang; Simon D Makombe; Erik J Schouten; Anthony D Harries Journal: Bull World Health Organ Date: 2007-07 Impact factor: 9.408
Authors: Henry M Selke; Sylvester Kimaiyo; John E Sidle; Rajesh Vedanthan; William M Tierney; Changyu Shen; Cheryl D Denski; Adrian R Katschke; Kara Wools-Kaloustian Journal: J Acquir Immune Defic Syndr Date: 2010-12 Impact factor: 3.731
Authors: Elvin H Geng; Denis Nash; Andrew Kambugu; Yao Zhang; Paula Braitstein; Katerina A Christopoulos; Winnie Muyindike; Mwebesa Bosco Bwana; Constantin T Yiannoutsos; Maya L Petersen; Jeffrey N Martin Journal: Curr HIV/AIDS Rep Date: 2010-11 Impact factor: 5.071
Authors: Tom Decroo; Olivier Koole; Daniel Remartinez; Natacha dos Santos; Sergio Dezembro; Mariano Jofrisse; Freya Rasschaert; Marc Biot; Marie Laga Journal: Trop Med Int Health Date: 2014-02-12 Impact factor: 2.622
Authors: Kelly B Khabala; Jeffrey K Edwards; Bienvenu Baruani; Martin Sirengo; Phylles Musembi; Rose J Kosgei; Kizito Walter; Joseph M Kibachio; Monique Tondoi; Helga Ritter; Ewan Wilkinson; Tony Reid Journal: Trop Med Int Health Date: 2015-06-15 Impact factor: 2.622
Authors: Stephen Okoboi; Erin Ding; Steven Persuad; Jonathan Wangisi; Josephine Birungi; Susan Shurgold; Darius Kato; Maureen Nyonyintono; Aggrey Egessa; Celestin Bakanda; Paula Munderi; Pontiano Kaleebu; David M Moore Journal: AIDS Res Ther Date: 2015-11-12 Impact factor: 2.250
Authors: V Naanyu; J Ruff; S Goodrich; T Spira; M Bateganya; C Toroitich-Ruto; B Otieno-Nyunya; A M Siika; K Wools-Kaloustian Journal: BMC Health Serv Res Date: 2020-04-25 Impact factor: 2.655
Authors: Noelle Le Tourneau; Ashley Germann; Ryan R Thompson; Nathan Ford; Sheree Schwartz; Laura Beres; Aaloke Mody; Stefan Baral; Elvin H Geng; Ingrid Eshun-Wilson Journal: PLoS Med Date: 2022-03-22 Impact factor: 11.069